<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01154855</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00029568</org_study_id>
    <nct_id>NCT01154855</nct_id>
  </id_info>
  <brief_title>Periodontal Disease and Circulatory Microbial Components</brief_title>
  <acronym>CirCo</acronym>
  <official_title>Circulatory Microbial Components and Immune Regulators of Patients With Periodontal Disease and Rheumatoid Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this project is to study the immune activity of certain proteins present in the
      blood of patients with severe periodontal disease. Periodontal disease (gum disease) is the
      major cause of tooth loss among adults. Moderate to severe periodontal disease is reported to
      affect 5-15% of American adults. It begins with an infection of the tissues surrounding the
      teeth, and leads to a worsening inflammatory response. This study will aid in clarifying the
      way in which gum disease might affect certain systemic diseases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This project will have two specific goals: 1. Identify microorganism components in the serum
      of patients with severe periodontitis; and 2. Characterize the immune regulator activity of
      periodontitis serum. This proposed feasibility study will then aid in providing the support
      for an increased sample size and other design requirements for larger, more expanded human
      clinical trial testing.In this study, forty (40) subjects will be divided into 2 groups: 1)
      Healthy oral status group and 2) Severe periodontal disease. Patients will be clinically
      screened using standard periodontal measurements.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identify microorganism components in the serum of patients with severe periodontitis</measure>
    <time_frame>1hour</time_frame>
    <description>microorganism components will be analyzed in serum samples collected before teeth cleaning and again 5 minutes after teeth cleaning</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Characterize the immune regulator activity of periodontitis serum</measure>
    <time_frame>1 hour</time_frame>
    <description>microorganism components will be analyzed in serum samples collected before teeth cleaning and again 5 minutes after teeth cleaning</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Periodontal Disease</condition>
  <arm_group>
    <arm_group_label>Periodontitis</arm_group_label>
    <description>Patients with severe periodontal disease Intervention (Procedure/surgery): Prophylaxis; Gross debridement for diseased patients
Other Names:
Teeth cleaning
1 per patient at 2nd visit lasting approximately 1 hour.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy patients</arm_group_label>
    <description>Patients without periodontal (gum) disease Intervention (Procedure/surgery): Prophylaxis; Gross debridement for diseased patients
Other Names:
Teeth cleaning</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Prophylaxis ; Gross debridement for diseased patients</intervention_name>
    <description>1 per patient at 2nd visit lasting approximately 1 hour.</description>
    <arm_group_label>Periodontitis</arm_group_label>
    <arm_group_label>Healthy patients</arm_group_label>
    <other_name>Teeth cleaning</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Dental plaque samples evaluated for microbial DNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        40 adult subjects comprised of two populations: 1) healthy (n=20) and 2) severe periodontal
        disease (n=20)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  35 years or older

          -  Healthy patients or patients with severe periodontal disease

          -  Patients with or without Rheumatoid Arthritis

          -  Patients with at least 20 permanent teeth

        Exclusion Criteria:

          -  Patients undergoing long-term (over 2 weeks) antibiotic-related therapy 3 months prior
             to study inclusion

          -  Patients receiving periodontal treatment 12 months prior to study inclusion (INCLUDING
             CLEANINGS)

          -  Patients will be excluded if they receive long-term use of medications known to affect
             periodontal status such as anti-inflammatory drugs, aspirin and ibuprofen

          -  Patients on immunosuppressive therapies, including glucocorticoids or cyclosporines,
             are excluded from participation in this study (inhalers are allowed)

          -  History of metabolic bone diseases such as rheumatoid arthritis or post-menopausal
             osteoporosis

          -  Pregnant women or women attempting to become pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William V Giannobile, DDS, DMedSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <link>
    <url>http://www.dent.umich.edu/mcohr/patients/clinicalstudies</url>
    <description>MCOHR study information for patients</description>
  </link>
  <link>
    <url>http://www.med.umich.edu/engage/</url>
    <description>University of Michigan clinical research database for patients</description>
  </link>
  <reference>
    <citation>Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006 Feb 24;124(4):783-801. Review.</citation>
    <PMID>16497588</PMID>
  </reference>
  <reference>
    <citation>Forner L, Nielsen CH, Bendtzen K, Larsen T, Holmstrup P. Increased plasma levels of IL-6 in bacteremic periodontis patients after scaling. J Clin Periodontol. 2006 Oct;33(10):724-9. Epub 2006 Aug 10.</citation>
    <PMID>16901299</PMID>
  </reference>
  <reference>
    <citation>D'Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, Ready D, Tonetti MS. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res. 2004 Feb;83(2):156-60.</citation>
    <PMID>14742655</PMID>
  </reference>
  <reference>
    <citation>Garlet GP, Martins W Jr, Ferreira BR, Milanezi CM, Silva JS. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res. 2003 Apr;38(2):210-7.</citation>
    <PMID>12608917</PMID>
  </reference>
  <reference>
    <citation>Pussinen PJ, Paju S, Mäntylä P, Sorsa T. Serum microbial- and host-derived markers of periodontal diseases: a review. Curr Med Chem. 2007;14(22):2402-12. Review.</citation>
    <PMID>17896988</PMID>
  </reference>
  <results_reference>
    <citation>Marchesan J, Jiao Y, Schaff RA, Hao J, Morelli T, Kinney JS, Gerow E, Sheridan R, Rodrigues V, Paster BJ, Inohara N, Giannobile WV. TLR4, NOD1 and NOD2 mediate immune recognition of putative newly identified periodontal pathogens. Mol Oral Microbiol. 2016 Jun;31(3):243-258. doi: 10.1111/omi.12116. Epub 2015 Sep 10.</citation>
    <PMID>26177212</PMID>
  </results_reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 16, 2010</study_first_submitted>
  <study_first_submitted_qc>June 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2010</study_first_posted>
  <last_update_submitted>December 11, 2015</last_update_submitted>
  <last_update_submitted_qc>December 11, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>William Giannobile</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Periodontal disease</keyword>
  <keyword>Gum disease</keyword>
  <keyword>Dental</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Microorganisms</keyword>
  <keyword>Bacteria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontal Diseases</mesh_term>
    <mesh_term>Gingival Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

